Study of GS-0272 in Participants With Rheumatoid Arthritis

Summary

The goals of this clinical study are to learn more about the study drug, GS-0272, and its safety and tolerability following multiple doses in participants with rheumatoid arthritis (RA). The primary objectives of this study are to assess the safety and tolerability of multiple ascending doses of GS-0272 and to characterize the pharmacokinetics of GS-0272 following multiple doses of GS-0272, in participants with RA.

Timeline

Start

2023-09-28

Primary completion

2026-05-11

Completion

2026-05-11

Outcome

Outcome not reported

Stopped: “Study terminated due to lack of efficacy.”

Drugs

Indications